Copyright
©The Author(s) 2022.
World J Gastrointest Surg. Dec 27, 2022; 14(12): 1397-1410
Published online Dec 27, 2022. doi: 10.4240/wjgs.v14.i12.1397
Published online Dec 27, 2022. doi: 10.4240/wjgs.v14.i12.1397
Ref. | Publication year | Age | Gender | BMI | Neoadjuvant therapy | Tumour stage | Tumour location | Distance of tumour to anal verge |
de’Angelis[13] | 2015 | 64.91 ± 10.05 vs 67.16 ± 9.61 | 66% vs 66% | 25.19 ± 3.52 vs 24.53 ± 3.19 | 100% vs 100% | I: 65.6% vs 56.3%; II: 31.3% vs 40.6%; III: 3.1% vs 3.1% | Low rectum | 4 (2.5-5.0) vs 3.7 (2.5-5.0) |
Kanso et al[14] | 2015 | 59 ± 11 (32-79) vs 59 ± 11 (33-82) | 71% vs 77% | 24 ± 4 (17-32) vs 24 ± 4 (15-34) | 80% vs 79% | NR | Lower rectum | 1.6 ± 0.8 (0-3.5) vs 1.8 ± 0.9 (0-3.5) |
Pontallier et al[15] | 2016 | 62 (39-81) vs 62 (35-82) | 68% vs 62% | 25.5 vs 24.8 | 79% vs 88% | I: 21% vs 21%; II: 19% vs 14%; III: 60% vs 65% | Low rectum | 4 (2-6) vs 4 (2-6) |
Marks et al[16] | 2016 | 60 vs 59 | NR | 25.9 vs 26.4 | NR | I: 29.4% vs 23.5%; II: 70.6% vs 76.5% | Low rectum | < 4 vs < 4 |
Lelong et al[17] | 2017 | NR | 68% vs 58% | 24 (18.6-45.0) vs 24.2(17.7-32.7) | 88.2% vs 92.1% | I: 17.6% vs 23.7%; II: 70.6% vs 71.0%; III: 11.8% vs 5.3% | Low rectum | NR |
Denost et al[18] | 2018 | 64 (39-82) vs 63 (31-90) | 74% vs 64% | 25.1 (17.3-33.2) vs 25.6 (18.3-38.3) | 78% vs 84% | NR | Low rectum | 4 (2-6) vs 4 (2-6) |
Mege et al[19] | 2018 | 58 ± 14 vs 59 ± 13 | 68% vs 68% | 25 ± 4 vs 25 ± 3 | 85% vs 85% | I: 29.4% vs 11.8%; II: 67.6% vs 82.3%; III: 43.5% vs 47.8%; IV: 2.9% vs 5.9% | Low rectum | NR |
Rubinkiewicz et al[20] | 2018 | 64.3 ± 10.1 vs 60.3 ± 10.2 | 69% vs 69% | 26.10 ± 4.09 vs 27.10 ± 4.71 | 88.6% vs 88.6% | I: 42.9% vs 45.7%; II: 57.1% vs 54.3% | Low rectum | 2.90 ± 1.17 vs 3.19 ± 1.47 |
Roodbeen et al[21] | 2019 | 62.5 ± 10.7 vs 66.0 ± 9.2 | 82.9% vs 78% | 26.7 ± 1.9 vs 26.1 ± 4.0 | 43.9% vs 43.9% | I: 22.0% vs 19.5%; II: 36.6% vs 39%; III: 31.7% vs 31.7%; IV: 9.8% vs 9.8% | Low rectum | 2.0 (0.0-4.0) vs 1.5 (0.0-3.0) |
Rubinkiewicz et al[22] | 2019 | 60 (51-67) vs 64 (58-67) | 69% vs 69% | 26 (22.8-29.7) vs 26.5 (23.8-30.6) | 78.2% vs 82.6% | NR | Low rectum | 3(2-4) vs 4 (3-5) |
Ren et al[23] | 2021 | 65.78 ± 12.37 vs 67.16 ± 10.03 | 59.3% vs 56.2% | 22.87 ± 2.66 vs 23.05 ± 2.70 | 71.8% vs 65.6% | I: 34.3% vs 37.5%; II: 28.1% vs 31.2%; III: 31.2% vs 21.8% | Low rectum | 5.53 ± 0.98 vs 5.78 ± 0.94 |
Li et al[24] | 2022 | 55 ± 12 (23-78) vs 56 ± 12 (26-79) | 100% vs 100% | 23:0 ± 2.9 vs 22:9 ± 3.2 | 100% vs 100% | NR | Low rectum | 3.6 ± 0.9 (2.0-5.0) vs 3.8 ± 0.9 (1.4-5.0) |
- Citation: Bhattacharya P, Patel I, Fazili N, Hajibandeh S, Hajibandeh S. Meta-analysis of transanal vs laparoscopic total mesorectal excision of low rectal cancer: Importance of appropriate patient selection. World J Gastrointest Surg 2022; 14(12): 1397-1410
- URL: https://www.wjgnet.com/1948-9366/full/v14/i12/1397.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v14.i12.1397